| pubmed-article:21585705 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C0210657 | lld:lifeskim |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C1708063 | lld:lifeskim |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C0039260 | lld:lifeskim |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C0022771 | lld:lifeskim |
| pubmed-article:21585705 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:21585705 | pubmed:dateCreated | 2011-5-18 | lld:pubmed |
| pubmed-article:21585705 | pubmed:abstractText | The aim of this analysis is to investigate the mean incremental costs and life expectancy associated with two first-line treatments for advanced non-squamous non-small cell lung cancer (NSCLC) in Korea and Taiwan; bevacizumab plus cisplatin and gemcitabine (BevCG) and cisplatin plus pemetrexed (CP). | lld:pubmed |
| pubmed-article:21585705 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21585705 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21585705 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21585705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21585705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21585705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21585705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21585705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21585705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21585705 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21585705 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21585705 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21585705 | pubmed:issn | 1743-7563 | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:HsiaTe-ChunTC | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:AhnMyung-JuMJ | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:KimSang-WeSW | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:KimHeung... | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:KimJoo-HangJH | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:KangMijeongM | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:TsaiChun-Ming... | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:ChangJohn... | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:KangJin... | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:WalzerStefanS | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:BaeEun-JinEJ | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:WrightElaineE | lld:pubmed |
| pubmed-article:21585705 | pubmed:author | pubmed-author:ListerJohanna... | lld:pubmed |
| pubmed-article:21585705 | pubmed:copyrightInfo | © 2011 Blackwell Publishing Asia Pty Ltd. | lld:pubmed |
| pubmed-article:21585705 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21585705 | pubmed:volume | 7 Suppl 2 | lld:pubmed |
| pubmed-article:21585705 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21585705 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21585705 | pubmed:pagination | 22-33 | lld:pubmed |
| pubmed-article:21585705 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:meshHeading | pubmed-meshheading:21585705... | lld:pubmed |
| pubmed-article:21585705 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21585705 | pubmed:articleTitle | Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan. | lld:pubmed |
| pubmed-article:21585705 | pubmed:affiliation | Section of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. silkahn@skku.edu | lld:pubmed |
| pubmed-article:21585705 | pubmed:publicationType | Journal Article | lld:pubmed |
